Anaptysbio, Inc
ANAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001370053
No open-market purchases or sales by Anaptysbio, Inc insiders were filed in the last 90 days; 213 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Anaptysbio, Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- −3 vs. Q1 2022
- Shares held
- 31.2M
- +1.55M (+5.2%) vs. Q1 2022
- Total value
- $632.6M
- −$100.7M (−13.7%) vs. Q1 2022
- New holders
- 18
- 39 more added
- Sold out
- 21
- 39 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 213 | $2.03B |
| Q1 2026 | 208 | $1.55B |
| Q4 2025 | 179 | $1.42B |
| Q3 2025 | 166 | $980.2M |
| Q2 2025 | 148 | $816.2M |
| Q1 2025 | 153 | $742.8M |
| Q4 2024 | 136 | $468.9M |
| Q3 2024 | 160 | $1.13B |
| Q2 2024 | 135 | $746.6M |
| Q1 2024 | 133 | $658.1M |
| Q4 2023 | 119 | $646.4M |
| Q3 2023 | 116 | $544.5M |
| Q2 2023 | 116 | $614.9M |
| Q1 2023 | 113 | $675.4M |
| Q4 2022 | 118 | $1.02B |
| Q3 2022 | 114 | $830.6M |
| Q2 2022 | 124 | $632.6M |
| Q1 2022 | 131 | $735.4M |
| Q4 2021 | 136 | $964.4M |
| Q3 2021 | 127 | $748.8M |
| Q2 2021 | 122 | $720.6M |
| Q1 2021 | 122 | $628.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Anaptysbio, Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 251,804 | $5.11M | 0.00% | −160,843−39.0% | Reduced |
| Laurion Capital Management LP | 263,208 | $5.34M | 0.22% | +55,708+26.8% | Added |
| Blackstone Group Inc. | 328,720 | $6.67M | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 338,085 | $6.86M | 0.00% | +67,756+25.1% | Added |
| Geode Capital Management, LLC | 371,224 | $7.54M | 0.00% | +15,386+4.3% | Added |
| Baker Bros. Advisors LP | 427,179 | $8.67M | 0.05% | 00.0% | Unchanged |
| Palo Alto Investors LP | 431,024 | $8.75M | 0.76% | 00.0% | Unchanged |
| Great Point Partners LLC | 453,118 | $9.20M | 2.37% | −246,882−35.3% | Reduced |
| Rock Springs Capital Management LP | 572,300 | $11.6M | 0.34% | +9,000+1.6% | Added |
| Soleus Capital Management, L.P. | 643,575 | $13.1M | 2.09% | +643,575 | New |
| Deep Track Capital, LP | 672,569 | $13.7M | 0.94% | +113,787+20.4% | Added |
| Assenagon Asset Management S.A. | 687,564 | $14.0M | 0.06% | +687,564 | New |
| Deerfield Management Company, L.P. (Series C) | 772,000 | $15.7M | 0.33% | +772,000 | New |
| Point72 Asset Management, L.P. | 851,800 | $17.3M | 0.08% | −465,800−35.4% | Reduced |
| Frazier Life Sciences Management, L.P. | 899,700 | $18.3M | 1.72% | 00.0% | Unchanged |
| Woodline Partners LP | 920,638 | $18.7M | 0.31% | +86,711+10.4% | Added |
| Dimensional Fund Advisors LP | 922,941 | $18.7M | 0.01% | +31,090+3.5% | Added |
| State Street Corp | 1,155,881 | $23.5M | 0.00% | +197,786+20.6% | Added |
| Boxer Capital, LLC | 1,300,000 | $26.4M | 1.67% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,730,470 | $35.1M | 0.00% | −96,844−5.3% | Reduced |
| BlackRock Inc. | 1,773,898 | $36.0M | 0.00% | −49,497−2.7% | Reduced |
| Federated Hermes, Inc. | 2,304,097 | $46.8M | 0.13% | +700,910+43.7% | Added |
| Tang Capital Management LLC | 2,628,678 | $53.4M | 8.10% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 7,521,024 | $152.7M | 5.31% | 00.0% | Unchanged |
| Logos Global Management LP | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −152,885−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −68,201−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −38,833−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −37,285−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −26,479−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −16,300−100.0% | Sold out |
| Putnam Investments LLC | 0 | $0 | 0.00% | −15,513−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,630−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −13,614−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −10,702−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −9,862−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −9,716−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −9,433−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −8,700−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −8,310−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −3,890−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −1,366−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −213−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |